Covered recipient · General Payments record
NAYELIE YULIANA BENITEZ SANTOS
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2025
$648.80
- Reported across 15 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): (records>=3 OR total>=100) AND records>=2 AND NPI identity (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $648.80 | 15 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $167.08 | 3 |
| ConvaTec Inc. | $149.98 | 2 |
| Corcept Therapeutics | $131.39 | 5 |
| Molnlycke Health Care US, LLC | $102.07 | 1 |
| Novo Nordisk AS | $68.06 | 3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.22 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $648.80 | 15 |
Payment records · PY2025 (15)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.22 | 10/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1223034560 | CMS |
| ConvaTec Inc. | $6.00 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252579690 | CMS |
| ConvaTec Inc. | $143.98 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1252579692 | CMS |
| Corcept Therapeutics | $26.63 | 08/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214159796 | CMS |
| Corcept Therapeutics | $29.53 | 09/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214159814 | CMS |
| Corcept Therapeutics | $24.08 | 10/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214159866 | CMS |
| Corcept Therapeutics | $24.25 | 11/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214159858 | CMS |
| Corcept Therapeutics | $26.90 | 12/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1214159878 | CMS |
| Lilly USA, LLC | $124.99 | 08/14/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187288396 | CMS |
| Lilly USA, LLC | $10.37 | 09/30/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187299553 | CMS |
| Lilly USA, LLC | $31.72 | 10/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1187243972 | CMS |
| Molnlycke Health Care US, LLC | $102.07 | 11/13/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1185594208 | CMS |
| Novo Nordisk Inc | $24.41 | 07/21/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188726332 | CMS |
| Novo Nordisk Inc | $19.54 | 08/05/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188639938 | CMS |
| Novo Nordisk Inc | $24.11 | 11/04/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1189001224 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.